J0216 HCPCS Level II code: Injection, alfentanil hydrochloride, 500 micrograms
J0216 is the HCPCS code for “Injection, alfentanil hydrochloride, 500 micrograms” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0216Injection, alfentanil hydrochloride, 500 micrograms
Short description: Inj, alfentanil hcl, 500mcg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0216 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2023
Where J0216 sits
- 1J codesDrugs administered other than orally
- 2Active code J0216Injection, alfentanil hydrochloride, 500 micrograms
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0216 mean?
J0216 is the HCPCS code for “Injection, alfentanil hydrochloride, 500 micrograms” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0216?
CMS lists J0216’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0216
All J codesJ0207Injection, amifostine, 500 mgJ0208Injection, sodium thiosulfate (pedmark), 100 mgJ0209Injection, sodium thiosulfate (hope), 100 mgJ0210Injection, methyldopate hcl, up to 250 mgJ0211Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)J0215Injection, alefacept, 0.5 mgJ0217Injection, velmanase alfa-tycv, 1 mgJ0218Injection, olipudase alfa-rpcp, 1 mgJ0219Injection, avalglucosidase alfa-ngpt, 4 mgJ0220Injection, alglucosidase alfa, 10 mg, not otherwise specifiedJ0221Injection, alglucosidase alfa, (lumizyme), 10 mgJ0222Injection, patisiran, 0.1 mg